Skip to main content

Table 5 Comparison between case and control groups as regards oxygenation (Pao2/Fio2)

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

  

Group A

Group B

A/B^

Before

Median (IQR)

164.5

(147.8–229.5)

164.0

(147.0–194.3)

0.570

Range

105.0–400.0

103.0–255.0

After

Median (IQR)

191.0

(162.8–230.3)

177.5

(150.0–221.3)

0.279

Range

142.0–402.0

120.0–285.0

Difference

Median (IQR)

20.5

(− 6.8–41.5)

24.0

(− 10.0–54.8)

0.797

Range

− 30.0–60.0

− 100.0–150.0

p#

0.006*

0.212

 
  1. Negative values indicate reduction
  2. Md Median, IQR interquartile range
  3. ^Mann-Whitney test
  4. #Wilcoxon signed rank test
  5. *Significant p value > 0.05 NS; *p value < 0.05 S; **p value < 0.001 H